Press release
Preclinical Oncology Models Market Trends and Growth Opportunities Driven by Precision Cancer Drug Development and Immuno-Oncology Advancements
Preclinical Oncology Models Market
According to the latest research by InsightAce Analytic, the global Preclinical Oncology Models market will be valued at USD 1335.7 Million in 2024. It is expected to reach USD 3733.0 Million by 2034, with a CAGR of 10.9% during a forecast period of 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1093
Preclinical oncology models are integral to assessing the potential clinical effectiveness of emerging cancer therapies. With the growing emphasis on cancer immunotherapy, the demand for robust, clinically relevant preclinical models has intensified, addressing the complex translational challenges inherent to these treatments. Such models are critical for the accurate screening of drug candidates and the optimization of therapeutic strategies prior to entering clinical trials.
The market for preclinical oncology models is being propelled by several key drivers, including advancements in immuno-oncology, the development of targeted and innovative cancer therapies, and the expansion of oncology-focused research and development activities. Increasing reliance on predictive and reliable models-such as humanized mouse models and syngeneic tumor models-demonstrates the industry's focus on minimizing translational failures and enhancing clinical trial success rates.
Furthermore, the growing emphasis on rational combination therapy design and the early identification of predictive biomarkers is accelerating the adoption of advanced preclinical platforms. The introduction of novel immuno-oncology approaches, including T-cell therapies, bispecific antibodies, immune checkpoint inhibitors, and personalized cancer vaccines, has further elevated the need for sophisticated preclinical and translational research solutions.
The preclinical oncology models market remains highly fragmented, characterized by a diverse range of service providers operating across domestic and international markets, delivering specialized expertise to support the development and validation of next-generation cancer therapeutics.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
North America is anticipated to contribute to the Preclinical Oncology Models market because preclinical oncology models are required, cancer research funding is rising, and there is a large demand for cancer immunotherapies. In addition, the Asia Pacific Preclinical Oncology Models market is expected to register significant growth. The regional market expansion drivers include the development of cancer diagnostic and therapeutic technologies, the increased demand for targeted medicines, and the rising R&D activities in oncology clinical trials by industry participants.
Major market players operating in the Preclinical Oncology Models market include
Aragen Bioscience, vivoPharm Pty. Ltd. Bioduro, Crown Bioscience Inc., Charles River, Champion Oncology, Inc., Envigo, GenOway S.A., Hera BioLabs, MI Bioresearch Inc, Pharmatest Services, Taconic Biosciences, Inc., and The Jackson Laboratory.
Recent collaborations and agreements in the market:
• In December 2021, the Crown Bioscience facility in the United Kingdom grew. Crown Bioscience is a top contract research organization (CRO) for preclinical and translational drug development services. This expansion provides more imaging options to help observe and comprehend the course of the tumor and its response to potential treatments. The new imaging platform enables the execution of state-of-the-art preclinical research, providing advanced insights on possible medication candidates before clinical trials.
• In February 2021, Kibur Medical and Charles River Laboratories International, Inc. collaborated to give in vivo preclinical oncology studies exclusive access to their implantable microdevice (IMD).
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1093
Market Segments
Global Preclinical Oncology Models Market, by Product, 2022-2030 (Value US$ Mn)
• Patient-Derived Xenograft Models (PDX)
• Cell Line Derived Xenograft Models
• Syngeneic Models
• Genetically engineered mouse models (GEMMs)
• Orthotopic Models
• Custom Xenograft and Syngeneic Model
• Others
Global Preclinical Oncology Models Market, by Application, 2022-2030 (Value US$ Mn)
• Neuroblastoma
• Prostate Cancer
• Pancreatic Cancer
• Breast Cancer
• Colorectal Cancer
• Bladder Cancer
• Fibrosarcoma
• Kidney Cancer
• Liver Cancer
• Lung Cancer
• Lymphoma
• Skin Cancer
• Others
Global Preclinical Oncology Models Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Preclinical Oncology Models market
To receive an industry overview and future trends of the Preclinical Oncology Models market
To analyze the Preclinical Oncology Models market drivers and challenges
To get information on the Preclinical Oncology Models market value (US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Preclinical Oncology Models market industry
Read Overview Report- https://www.insightaceanalytic.com/report/global-preclinical-oncology-models-market/1093
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Preclinical Oncology Models Market Trends and Growth Opportunities Driven by Precision Cancer Drug Development and Immuno-Oncology Advancements here
News-ID: 4161593 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Cell-Free Protein Synthesis Market Trends in Enzyme Engineering and High Through …
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth USD 299.9 million in 2024 and is poised to reach USD 585.3 Million by the year 2034, growing at a CAGR of 7.0% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1445
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global cell-free…
Gastrointestinal Endoscopy Market Growth Driven by AI Integration Single-Use Dev …
InsightAce Analytic Pvt. Ltd. announced the publication of a market research report titled " Global Gastrointestinal Endoscopy Market By Type(Gastrointestinal Endotherapy, (ERCP Devices, Gastrointestinal Stents (Esophageal Stents, Biliary Stents, Pancreatic Stents), Balloon Dilators, Ultrasound Endoscopes, Biopsy Devices (Biopsy Forceps, Polypectomy Snares, Other Biopsy Devices), Hemostasis Devices, Retrieval Devices, Others), Gastrointestinal Endoscopes and Endoscopic Systems (Gastrointestinal Videoscopes (Gastroscopes, Colonoscopes, Duodenoscopes, Sigmoidoscopes, Enteroscopes, Anoscopes), Visualization Systems, Capsule Endoscopes), End-User (Hospitals, Ambulatory Surgery…
Sensor-based Smart Catheters Market Outlook Featuring Multi Lumen Single Lumen C …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Sensor-based Smart Catheters Market- by Product Type (Temperature Sensing Foley Catheter, Pressure Catheter, Mapping Catheter and Others), Catheter Type (Single Lumen and Multi Lumen), Material (Silicon, Polytetrafluoroethylene, and Others), Application (Cardiovascular, Urology, Gynaecology, Neurovascular and Others), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the global sensor-based…
Petcare IoT Platforms Market Outlook Featuring Adoption of Connected Pet Product …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Petcare IoT Platforms Market- by Pet Type (Dog, Cat, Fish, And Other Pet Types), Products (pet wearables [safety & security (GPS collars), Identification (smart tags), tracking (smart collars), behavior monitoring (bark collars), facilitation (temperature scanners, veterinarian appointments), medical diagnostics and treatment devices], connected pet products [Pet feeders & bowls, pet crates & beds, pet doors,…
More Releases for Model
Animal Model Market
The Global Animal Model Market, detailed in the TechSci Research report titled, "Animal Model Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028," exhibited a value of USD 1.67 billion in 2022, poised to grow at a Compound Annual Growth Rate (CAGR) of 7.64% from 2024 to 2028. This comprehensive analysis delves into the intricate web of factors driving the market, including the global burden of chronic…
Executing a Business Model Transformation with A Business Model Canvas
Business model transformation is the process of changing the way a company operates, with the aim of improving its overall performance. This transformation often involves significant changes to a company's existing business model. To ensure that the transformation process is successful, companies can use a tool called the business model canvas. Get a free business model canvas here: https://digitalleadership.com/unite-articles/extended-business-model-canvas/
Steps in Executing a Business Model Transformation with A Business Model Canvas
Business…
Fourth Party Logistics Market : Industry Innovator Model, Solution Integrator Mo …
The fourth party logistics market was valued at $57.9 billion in 2021, and is estimated to reach $111.7 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031.
Fourth party logistics, popularly known as 4PL, is the model of outsourcing of logistics operations, where the service provider integrates with the company's supply chain department. This logistics partner is responsible for assessing, designing, building, running, and measuring integrated supply…
How Drizly Works: Business Model & Revenue Model
‘Slow and steady wins the race.’
Such is the case with the world’s leading alcohol marketplace, Drizly which carved a unique, step-by-step growth strategy for itself and eventually, succeeded in transforming the way alcohol is bought and sold across various continents. Co-founded in 2012 by Cory Rellas and Nick Rellas, the Boston-based start-up which was one of the first few on-demand liquor delivery apps to make its way into the market,…
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market
Developing Regions to Overpower Developed Ones With Regard to Demand
The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their…
Cloud Computing in Healthcare Market By Deployment Model (Public- cloud deployme …
Industry Outlook and Trend Analysis
The Cloud Computing in Healthcare Market was worth USD 3.05 billion in 2014 and is expected to reach approximately USD 16.25 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 20.43% during the forecast period. Cloud computing, commonly alluded to as 'the cloud', is a technique to access and store the information and projects over the internet. The cloud computing is…
